PERSPECTA

News from every angle

Back to headlines

Weight-Loss Drug Semaglutide Approved in Tablet Form Across EU

The active ingredient Semaglutide, used in weight-loss medication, has received EU-wide approval for its tablet form, offering an alternative to injections.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.